ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Glucocortocoids"

  • 2017 American Transplant Congress

    Glucocorticoid Receptor – Relaxin Signaling in Liver Transplant Ischemia-Reperfusion Injury (IRI): From Bench-to-Bedside.

    S. Kageyama,1 K. Nakamura,1 R. Sossa,2 E. Reed,2 N. Datta,1 A. Zarrinpar,1 R. Busuttil,1 J. Kupiec-Weglinski.1

    1The Dumont-UCLA Transplant Center, Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, CA; 2Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA

    Background: Glucocorticoid receptor (GR) serves as a receptor for relaxin (RLX), a pregnancy hormone, with novel vasoactive and tissue remodeling properties. A phase III clinical…
  • 2017 American Transplant Congress

    Kidney-Specific Immunosuppression without Adverse Systemic Effects.

    D. Kentrup,1 K. Schuette-Nuetgen,1 H. Pawelski,1 H. Pavenstädt,1 S. Hermann,2 M. Schaefers,2 G. Larbig,3 A. Kuebelbeck,3 S. Reuter.1

    1Department of Medicine D, University Hospital Muenster, Muenster, Germany; 2European Institute for Molecular Imaging - EIMI, University Hospital Muenster, Muenster, Germany; 3Merck KGaA, Darmstadt, Germany

    Purpose: Immunosuppressive therapy is often accompanied by severe adverse effects. To overcome this, the aim of this study was the evaluation of a kidney-specific drug…
  • 2017 American Transplant Congress

    Dexamethasone Prolongs Cardiac Allograft Survival in a Murine Model Through Myeloid-Derived Suppressor Cells.

    T. Nakao,1 T. Nakamura,1 K. Masuda,1 T. Matsuyama,1 H. Ushigome,1 E. Ashihara,2 N. Yoshimura.1

    1Organ Transplantation and Regenerative Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; 2Clinical and Translational Physiology, Kyoto Pharmaceutical University, Kyoto, Japan

    Recently, myeloid-derived suppressor cells (MDSCs) have attracted considerable attention because of their cancer-promoting and immunosuppressive effects. The glucocorticoid (GC) dexamethasone (Dex) is an important immunosuppressive…
  • 2017 American Transplant Congress

    Avascular Necrosis in Kidney Transplant Recipients: Recent Data from a Cohort Study.

    P. Perrin,1 R. Felten,2 S. Caillard,1 M. Schaeffer,3 B. Moulin,1 R.-M. Javier.2

    1Nephrology, Transplantation Department, University Hospital, Strasbourg, France; 2Rheumatology Department, University Hospital, Strasbourg, France; 3Public Health Department, University Hospital, Strasbourg, France

    Avascular osteonecrosis (AVN) is the most disabling bone complication after kidney transplantation (KT). Its incidence decreased from 15% to 4% after the introduction of cyclosporine…
  • 2017 American Transplant Congress

    Outcomes Following Solitary Pancreas Transplantation – Do Steroids Matter?

    C. Chan, I. Tang, J. Oberholzer, M. Campara.

    University of Illinois Hospital, Chicago

    Background: Corticosteroids remain the cornerstone of maintenance immunosuppression following pancreas transplantation but are associated with significant short- and long-term complications. Data regarding steroid sparing regimens…
  • 2017 American Transplant Congress

    Recurrence of IgA Nephropathy After Kidney Transplantation in Maintenance Steroids versus Steroid Avoidance Regimens: A UNOS/OPTN Analysis.

    N. Leeaphorn, N. Garg, E. Khankin, F. Cardarelli, M. Pavlakis.

    Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA

    Background: There has been an increase in the use of steroid-avoidance regimens. However, there is some evidence to suggest that steroid avoidance may be associated…
  • 2016 American Transplant Congress

    Clinical Factors That Determine the Appropriateness of Early Steroid Withdrawal.

    S. Bae, A. Massie, S. DiBrito, X. Luo, L. Kucirka, D. Segev.

    Johns Hopkins, Baltimore, MD.

    Early steroid withdrawal (ESW) has been a popular option for recipients with low-immunological risk. However, no quantitative tools are available to assess the risk, i.e.…
  • 2016 American Transplant Congress

    Comparison of Efficacy of Different Regimens for Treating Recurrent IgA Nephropathy After Kidney Transplantation.

    G. Chen, C. Wang, L. Chen, J. Qiu, C. Wang, J. Fei, S. Deng, J. Li, G. Huang, Q. Fu.

    Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

    Background Recurrent IgA nephropathy is a common complication after kidney transplantation. How to treat recipients with recurrent IgA nephropathy is still controversial. There are two…
  • 2015 American Transplant Congress

    Human Leukocyte Antigen Mismatch and Steroid Maintenace in Kidney Transplantation

    K. Sureshkumar, R. Marcus, B. Chopra.

    Nephrology and Hypertension, Allegheny General Hospital, Pittsburgh, PA.

    Kidney transplant recipients (KTRs) with zero/minimal HLA mismatches against their donors enjoy superior long term outcomes related to diminished immune response of the recipient against…
  • 2015 American Transplant Congress

    The Use of a Nurse Practitioner Led Transitional Diabetes Clinic Following Transplantation

    N. Cardinez, P. Segal, S. Trohonel.

    Endocrinology Department, University Health Network - Toronto General Hospital, Toronto, ON, Canada.

    The incidence of new onset diabetes after transplant [NODAT] ranges from 2% to 53%, also Type1 [T1DM] and Type 2 [T2DM] diabetes are common in…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences